Haemonetics Corp. buy Citigroup Inc.
Start price
07.10.25
/
50%
€41.40
Target price
07.10.26
€54.71
Performance (%)
18.84%
Price
02.04.26
€49.40
Summary
This prediction is currently active. The prediction currently has a performance of 18.84%. This prediction currently runs until 07.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | - | - |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its price target lowered by analysts at Citigroup Inc. from $78.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€65.00
09.07.25
09.07.25
€76.78
09.07.26
09.07.26
-23.38%
02.04.26
02.04.26

